FDA inspection

BioLife Plasma Services LP: FDA inspection ending Feb 13, 2020

FDA inspection 1123399 · Voluntary Action Indicated (VAI) · Oklahoma City, OK

Key facts

Inspection ID	1123399
Firm	BioLife Plasma Services LP
FEI number	3015856258
Address	4275 Nw 63rd St
City	Oklahoma City
State	OK
ZIP	73116-1538
Fiscal year	2020
Inspection end date	Feb 13, 2020
Classification	Voluntary Action Indicated (VAI)
Project area	Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood & Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products\|Blood and Blood Products
Product type	Biologics

At a glance

None Citations
1–9 Posted citations
No Warning letter followed
Yes Form FDA 483 issued
No Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections